Fu­ji­film ex­pands in US af­ter $100M deal for Atara's man­u­fac­tur­ing site and em­ploy­ees

Atara Bio­ther­a­peu­tics has worked on ad­vanc­ing its al­lo­gene­ic T-cell ther­a­py plat­form for pa­tients with can­cer and au­toim­mune dis­ease for years, with much of the fo­cus on the ever-tricky task of man­u­fac­tur­ing such a ther­a­py. On Wednes­day, the com­pa­ny an­nounced a deal to hand its Cal­i­for­nia man­u­fac­tur­ing site over to Fu­ji­film Diosynth in ex­change for $100 mil­lion up­front and a long-term li­cens­ing deal.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER